Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

UC San Diego Medical Center Selects Cannon Design for Expansion Project

 

June 25, 2008  |  

UC San Diego Medical Center has taken the next step toward building a new inpatient tower on its East Campus-La Jolla location by selecting Cannon Design, an internationally ranked architectural, engineering and planning firm, to lead the project. Cannon Design is recognized as one of the design industry leaders in academic medical centers, with a particular emphasis on cancer care.

Pending final approval by the University of California, Board of Regents, the new inpatient tower is expected to break ground in 2012 with a completion date of 2015. The project will double the capacity of the 119-bed Thornton Hospital allowing the hospital to operate all of its 505 licensed beds, which is not possible today due to facility limitations.

“The vibrant San Diego region is seeing its population both grow and age,” said Rich Liekweg, chief executive officer for UC San Diego Medical Center. “The new tower will offer San Diegans access to a unique combination of clinical innovation and compassionate care that can only be experienced at an academic medical center.”

UC San Diego’s long-term objective is to build a major University Medical Center on the East Campus in proximity to the School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, to better integrate the University’s extensive clinical programs and regional specialty centers with its educational and biomedical research programs.

“We are very excited for our team to have been selected for this important project,” said Scott Reed, AIA, principal, West Coast and Pacific Northwest regional market and practice leader at Cannon Design.

# # #

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu




Media Contact

Share This Article


Related News

9/23/2020
Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellula ...
9/21/2020
Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
9/17/2020
A consortium of 12 health systems, led by UC San Diego Health, introduces COVID19questions.org, a site where clinicians, researchers, patients and the general public are invited to submit questions th ...
9/16/2020
Early detection and intervention stanched the first known introductions of the SARS-CoV-2 virus into North America and Europe, validating the effectiveness of quick, comprehensive testing and contact ...



Follow Us